You’re probably well versed in the benefits of LED for your face by now, but did you know it’s also a powerful technology when it comes to promoting scalp and hair health too? The best LED devices for ...

SAN DIEGO, April 30, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the initiation of a Phase 3 registrational program to evaluate the efficacy, safety and ...

MR-107A-02 demonstrated notable reduction in opioid usage over the entire treatment phase by reducing opioid use versus placebo and by showing a higher number opioid-free patients than placebo ...

Semaglutide, a glucagon-like peptide-1 receptor agonist, is a candidate for the treatment of metabolic dysfunction–associated steatohepatitis (MASH). In this ongoing phase 3, multicenter ...

this Phase 1b/2a trial will also investigate the ability of IFx-Hu2.0 to increase the anti-tumor response rate when used alongside Keytruda® in first line treatment of CPI naïve, metastatic MCC.

Philippe Martin, Viatris’s Chief R&D Officer, highlighted the potential for MR-107A-02 to become a first-line treatment for acute pain without the risks associated with opioids.

Here, we pick three of the most exciting studios ... Mexico City-based architecture and design practice is, in fact, led by co-directors Ana Paula Ruiz Galindo and Mechy Reuss. They explain that their ...

Autonomix Medical, Inc. has announced its plans to commence a follow-on phase of its proof-of-concept ... transvascular diagnosis and treatment of diseases involving the peripheral nervous system ...

The majority of women are diagnosed at an early stage, when treatment outcomes are generally favorable.* For women with high-intermediate risk disease, adjuvant radiotherapy — particularly ...

GOSHEN, Ind. (WSBT) — Goshen is moving forward with major plans to build an entirely new water treatment plant. The city has applied for a $68 million loan to improve the water supply.